Global /Switzerland /Basic Materials /Specialty Chemicals /DSFIR
chevron_leftBack

DSM-Firmenich AG

DSFIR
AMS: DSFIR Delayed
92.92EUR 2.1%
105.30 USD
As of 24 April 2025, DSM-Firmenich AG has a market cap of $27.25B USD, ranking #708 globally and #22 in Switzerland. It ranks #39 in the Basic Materials sector, and #11 in the Specialty Chemicals industry.
Global Rank
708
Country Rank
22
Sector Rank
39
Industry Rank
11
Key Stats
Market Cap
$27.25BUSD
24.05B EUR
Enterprise Value
$30.37BUSD
26.8B EUR
Revenue (TTM)
$14.5BUSD
12.8B EUR
EBITDA (TTM)
$1.81BUSD
1.6B EUR
Net Income (TTM)
$283.31MUSD
250.0M EUR
EBITDA Margin
12%
Profit Margin
2%
PE Ratio
96.8
Company Profile
Country (HQ)
Sector
Basic Materials
Industry
Specialty Chemicals
CEO
Dimitri de Vreeze open_in_new
Employees
26,301
Founded
1902
Website
dsm-firmenich.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.1% 3.1% 0.1% -6.2% -19% -12%

Markets

Exchange Ticker Price
Euronext Amsterdam
MIC: XAMS
PRIMARY
DSFIR
DSM Firmenich AG
ISIN: CH1216478797
Shares Out.:
265.272M1 Shares Float: 249.218M2
TV:
SA:
YF:
GF:
BA:
MS:
92.92 EUR
London Stock Exchange
MIC: XLON
0AC9
DSM Firmenich AG
ISIN: CH1216478797
TV:
SA:
YF:
GF:
BA:
MS:
90.06 EUR
OTC Markets
MIC: OTCM
DSFIY
DSM Firmenich AG ADR
ISIN: US23346J1034
TV:
SA:
YF:
GF:
BA:
MS:
10.42 USD
OTC Markets
MIC: OTCM
DSMFF
DSM Firmenich AG
ISIN: CH1216478797
TV:
SA:
YF:
GF:
BA:
MS:
100.08 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

Similar Companies

Industry: Specialty Chemicals (Switzerland)
Name
Market Cap diff.
Givaudan S.A.
GIVN
$41.97B
34.83B CHF
54%
Sika AG
SIKA
$37.41B
31.05B CHF
37%
EMS-CHEMIE HOLDING AG
EMSN
$16.09B
13.36B CHF
-41%
Clariant AG
CLN
$3.47B
2.88B CHF
-87%
Gurit Holding AG
GURN
$69.57M
57.73M CHF
-100%
Industry: Specialty Chemicals (Global)
Name
Market Cap diff.
Linde plc
LIN
$211.96B
678%
L'Air Liquide S.A.
AI
$114.15B
100.73B EUR
319%
The Sherwin-Williams Co.
SHW
$82.92B
204%
Ecolab Inc.
ECL
$67.49B
148%
Air Products and Chemicals, Inc.
APD
$58.9B
116%